![[Next-Generation Sequencing Book]](https://www.bioinformatics.org/images/ack_banners/NGS-Book-1-728x90.png)
-
The AFP has this story on restrictions placed on the Harvard Oncomouse:
``The European Patent Office placed new restrictions Tuesday on a patent it had issued for a genetically modified rodent that its inventors claim can be useful in cancer research.
``Using the patented technique, scientists can alter a gene in rodents and make them more likely to develop tumours, which means they can be used to test whether a material might contain carcinogens.
``Spokesman Rainer Osterwalder said the EPO had decided that Harvard University's so-called Oncomouse patent would now only apply to mice rather than any kind of rodent.''
Full story:
http://story.news.yahoo.com/news?tmpl=story&cid=1539&ncid=1539&e=5&u=/afp/20040706/sc_afp/europe_science_health_040706192147
More on the Oncomouse:
http://www.cbc.ca/news/features/harvard_mouse.html
http://www.cela.ca/celacourts/detail.shtml?x=1319
![[Photo]](https://www.bioinformatics.org/images/photo.php?photo_id=5)
Discussion forums: Yahoo!: Europe's patent office restricts genentic rodent patent
Expanded view | Monitor forum | Save place
Start a new thread:
You have to be logged in to post a reply.